[go: up one dir, main page]

WO2009058690A3 - Nell-1 compositions - Google Patents

Nell-1 compositions Download PDF

Info

Publication number
WO2009058690A3
WO2009058690A3 PCT/US2008/081168 US2008081168W WO2009058690A3 WO 2009058690 A3 WO2009058690 A3 WO 2009058690A3 US 2008081168 W US2008081168 W US 2008081168W WO 2009058690 A3 WO2009058690 A3 WO 2009058690A3
Authority
WO
WIPO (PCT)
Prior art keywords
nell
compositions
antiangiogenesis
angiogenesis
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/081168
Other languages
French (fr)
Other versions
WO2009058690A2 (en
Inventor
Kang Ting
Chia Soo
Xinli Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to CA2704190A priority Critical patent/CA2704190A1/en
Priority to EP08844676A priority patent/EP2214697A4/en
Publication of WO2009058690A2 publication Critical patent/WO2009058690A2/en
Publication of WO2009058690A3 publication Critical patent/WO2009058690A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides an angiogenesis or antiangiogenesis composition including a Nell-1 protein and methods of making and using the same.
PCT/US2008/081168 2007-10-30 2008-10-24 Nell-1 compositions Ceased WO2009058690A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2704190A CA2704190A1 (en) 2007-10-30 2008-10-24 Nell-1 compositions
EP08844676A EP2214697A4 (en) 2007-10-30 2008-10-24 COMPOSITIONS OF NELL-1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98390307P 2007-10-30 2007-10-30
US60/983,903 2007-10-30

Publications (2)

Publication Number Publication Date
WO2009058690A2 WO2009058690A2 (en) 2009-05-07
WO2009058690A3 true WO2009058690A3 (en) 2009-09-24

Family

ID=40591716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/081168 Ceased WO2009058690A2 (en) 2007-10-30 2008-10-24 Nell-1 compositions

Country Status (3)

Country Link
EP (1) EP2214697A4 (en)
CA (1) CA2704190A1 (en)
WO (1) WO2009058690A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2411406B1 (en) * 2009-03-25 2017-03-01 The Regents of The University of California Isoform nell-1 peptide
WO2019210080A1 (en) * 2018-04-25 2019-10-31 The Regents Of The University Of California Methods and compositions for skeletal and neurological disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060053503A1 (en) * 2004-07-30 2006-03-09 Ut-Battelle, Llc Cranial and vertebral defects associated with loss-of-function of Nell
US20060292670A1 (en) * 2003-02-07 2006-12-28 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687462B2 (en) * 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
KR20070121669A (en) * 2005-02-16 2007-12-27 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 Pharmaceutical compositions for the treatment or prevention of bone conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060292670A1 (en) * 2003-02-07 2006-12-28 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US20060053503A1 (en) * 2004-07-30 2006-03-09 Ut-Battelle, Llc Cranial and vertebral defects associated with loss-of-function of Nell

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KARAGIANNIS, E. D. ET AL.: "Anti-angiogenic peptides identified in thrombospondin type I domains", BIOCHEM. BIOPHY. RES. COM., vol. 359, 2007, pages 63 - 69, XP022103143 *
KURODA, S. ET AL.: "Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL1 and NELL2", BIOCHEM. BIOPHY. RES. COM., vol. 265, 1999, pages 79 - 86, XP005100839 *
See also references of EP2214697A4 *
ZHANG, X. ET AL.: "Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development", J. BONE MINER. RES., vol. 18, no. 12, 2003, pages 2126 - 2134, XP009057038 *

Also Published As

Publication number Publication date
CA2704190A1 (en) 2009-05-07
EP2214697A2 (en) 2010-08-11
WO2009058690A2 (en) 2009-05-07
EP2214697A4 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
WO2007127841A3 (en) Compositions and methods of preparation thereof
WO2008121767A3 (en) Stitched polypeptides
WO2008014008A3 (en) Compositions and methods for modulating angiogenesis
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2008103935A3 (en) Novel tobacco compositions and methods of making
WO2008060705A8 (en) Anti-dll4 antibodies and methods using same
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
WO2007038629A3 (en) Dry platelet composition
WO2006050477A3 (en) Anti-microbial compositions and methods of making and using the same
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
WO2011072099A3 (en) Compositions and methods comprising protease variants
WO2006017538A3 (en) Hk1-binding proteins
WO2008034013A3 (en) Medical devices and methods of making the same
WO2007124090A3 (en) Lyophilized therapeutic peptibody formulations
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2007044026A3 (en) Compositions comprising modified collagen and uses therefore
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
MX286273B (en) Compositions and methods for inhibition of the jak pathway.
WO2010065969A8 (en) Sparc binding scfcs
WO2007124302A3 (en) Bone graft composition
WO2009009041A3 (en) Compositions and methods for modulating a kinase cascade
MY148286A (en) Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
WO2008112192A3 (en) Epha3 antibodies for the treatment of solid tumors
WO2008150537A3 (en) Silica particles and methods of making and using the same
WO2007127506A8 (en) Anti-ephrinb2 antibodies and methods using same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2008844676

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2704190

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08844676

Country of ref document: EP

Kind code of ref document: A2